A panel of p16INK4A, MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma

International Journal of Cancer

Volumn 123, Issue 12, 2008, Pages 2767-2773

  Hoevenaars, Brigiet M ^a   Van Der Avoort, Irene A M ^a   De Wilde, Peter C M ^a   Massuger, Leon F A G ^a   Melchers, Willem J G ^a   De Hullu, Joanne A ^a   Bulten, Johan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HPV; MIB1; p16INK4A; p53; Vulvar carcinoma; Vulvar intraepithelial neoplasia

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; PROTEIN P53; VIRUS DNA;

ADULT; ARTICLE; ASSAY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; VULVA CANCER; VULVA CARCINOMA; VULVA INTRA EPITHELIAL NEOPLASIA; WART VIRUS;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UBIQUITIN-PROTEIN LIGASES; VULVAR NEOPLASMS;

EID: 57349115531     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23857     Document Type: Article

References (48)

1. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 1993;17:133-45.
2. Preti M, van Seters M, Sideri M, van Beurden M. Squamous vulvar intraepithelial neoplasia. Clin Obstet Gynecol 2005;48:845-61.
3. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, Haefner H, Neill S. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology. ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005;50:807-10.
4. Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2005;47:340-7.
5. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000;24:429-41.
6. Fox H, Wells M. Recent advances in the pathology of the vulva. Histopathology 2003;42:209-16.
7. van Beurden M, van der Vange N, Ten Kate FJ, de Craen AJ, Schilthuis MS, Lammes FB. Restricted surgical management of vulvar intraepithelial neoplasia 3: focus on exclusion of invasion and on relief of symptoms. Int J Gynecol Cancer 1998;8:73-7.
8. Hording U, Daugaard S, Junge J, Lundvall F. Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 1996;15:230-4.
9. van der Avoort IAM, Shirango H, Hoevenaars BM, Grefte JM, de Hullu JA, de Wilde PC, Bulten J, Melchers WJ, Massuger LFAG. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 2006;25:22-9.
10. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005;97:645-51.
11. Sharpless NE, DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 1999;9:22-30.
12. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
13. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
14. Bulten J, van der Laak JA, Gemmink JH, Pahlplatz MM, de Wilde PC, Hanselaar AG. MIB1, a promising marker for the classification of cervical intraepithelial neoplasia. J Pathol 1996;178:268-73.
15. Kruse AJ, Baak JP, de Bruin PC, Jiwa M, Snijders WP, Boodt PJ, Fons G, Houben PW. The HS Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol 2001;193:48-54.
16. Modesitt SC, Groben PA, Walton LA, Fowler WC Jr, Van Le L. Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors. Gynecol Oncol 2000;76:51-5.
17. Salvesen HB, Iversen OE, Akslen LA. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. Clin Cancer Res 1998;4:2779-85.
18. van Hamont D, Bulten J, Shirango H, Melchers WJ, Massuger LF, de Wilde PC. Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models. Carcinogenesis 2008;29:840-5.
19. Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP. Carcinoma of the vulva: HPV and p53 mutations. Oncogene 1994;9:1655-9.
20. Kurman RJ, Norris HJ, Wilkinson EJ. Tumors of the cervix, vagina, and vulva. Atlas of tumor pathology. 3rd series edn. Fascicle 4. Washington: Armed Forces Institute of Pathology (AFIP), 1992.
21. Wilkinson EJ. Premalignant and malignant tumors of the vulva. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract, 2nd edn. New York: Springer-Verlag, 2002. 99-149.
22. van der Avoort IAM, van der Laak JA, Paffen A, Grefte JMM, Massuger LFAG, de Wilde PCM, de Hullu JA, Bulten J. MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol 2007;20:770-8.
23. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B, Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-9.
24. Melchers WJ, Bakkers JM, Wang J, de Wilde PC, Boonstra H, Quint WG, Hanselaar AG. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 1999;155:1473-8.
25. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
26. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
27. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006;13:8-15.
28. Samama B, Lipsker D, Boehm N. p16 expression in relation to human papillomavirus in anogenital lesions. Hum Pathol 2006;37:513-19.
29. Riethdorf S, Neffen EF, Cviko A, Loning T, Crum CP, Riethdorf L. p16 expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004;35:1477-83.
30. Santos M, Landolfi S, Olivella A, Lloveras B, Klaustermeier J, Suarez H, Alos L, Puig-Tintore LM, Campo E, Ordi J. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006;30:1347-56.
31. Bulten J, van der Avoort IAM, Melchers WJ, Massuger LF, Grefte JM, Hanselaar AG, de Wilde PC. p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia. Gynecol Oncol 2006;101:487-94.
32. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003;27:1463-70.
33. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465-72.
34. Blokx WA, de Jong EM, de Wilde PC, Bulten J, Link MM, Ruiter DJ, van de Kerkhof PC. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Mod Pathol 2003;16:869-78.
35. Lu DW, El-Mofty SK, Wang HL. Expression of p16. Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus. DNA Mod Pathol 2003;16:692-9.
36. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003;162:747-53.
37. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
38. Brandenberger AW, Rudlinger R, Hanggi W, Bersinger NA, Dreher E. Detection of human papillomavirus in vulvar carcinoma. A study by in situ hybridisation. Arch Gynecol Obstet 1992;252:31-5.
39. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet Gynecol 1997;89:81-4.
40. Pinto AP, Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol 2004;92:856-65.
41. Brustmann H, Naude S. Expression of topoisomerase IIα. Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol 2002;86:192-9.
42. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30.
43. Lerma E, Esteller M, Herman JG, Prat J. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol 2002;33:1120-5.
44. Nogueira MC, Guedes Neto EP, Rosa MW, Zettler E, Zettler CG. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 2006;12:153-7.
45. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol 2008;27:125-35.
46. Stoler MH, Mills SE, Frierson HF. The vulva and vagina. In: Mills SE, ed. Sternberg's diagnostic surgical pathology 2004. Philadelphia: Lippincott Wiliams & Wilkins, 2004. 2333-76.
47. Liegl B, Regauer S. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN). Histopathology 2006;48:268-74.
48. Medeiros F, Nascimento AF, Crum CP. Early vulvar squamous neoplasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol 2005;12:20-6.